Givosiran Interactions
There are 239 drugs known to interact with givosiran, along with 1 disease interaction, and 1 alcohol/food interaction. Of the total drug interactions, 45 are major, 191 are moderate, and 3 are minor.
- View givosiran alcohol/food interactions (1)
- View givosiran disease interactions (1)
Medications known to interact with givosiran
Note: Showing generic names only.
- acetaminophen
- acyclovir
- adefovir
- alosetron
- amikacin
- amikacin liposome
- amitriptyline
- amoxapine
- amphetamine
- amphotericin b
- amphotericin b cholesteryl sulfate
- amphotericin b lipid complex
- amphotericin b liposomal
- anagrelide
- aripiprazole
- asenapine
- asparaginase erwinia chrysanthemi
- asparaginase escherichia coli
- atomoxetine
- bacitracin
- balsalazide
- bedaquiline
- bendamustine
- benzgalantamine
- black cohosh
- bleomycin
- botulism immune globulin
- brentuximab
- brexpiprazole
- cabazitaxel
- caffeine
- calaspargase pegol
- cannabidiol
- capreomycin
- carvedilol
- cefamandole
- cefazolin
- cefepime
- cefixime
- cefoperazone
- cefotaxime
- cefotetan
- cefoxitin
- cefpodoxime
- cefprozil
- ceftazidime
- cefuroxime
- cephradine
- cevimeline
- chlorambucil
- chlorpheniramine
- chlorpromazine
- cidofovir
- ciprofloxacin
- cisplatin
- clindamycin
- clofarabine
- clomipramine
- clozapine
- codeine
- colistimethate
- cyclobenzaprine
- cyclophosphamide
- cyclosporine
- cytomegalovirus immune globulin
- daclizumab
- daptomycin
- darifenacin
- deferasirox
- desipramine
- deutetrabenazine
- dexfenfluramine
- dextroamphetamine
- dextromethorphan
- diatrizoate
- dimethyl fumarate
- diphenhydramine
- diroximel fumarate
- donepezil
- doxepin
- doxorubicin
- doxorubicin liposomal
- duloxetine
- fedratinib
- fenfluramine
- fezolinetant
- flecainide
- flucytosine
- fluoxetine
- fluphenazine
- flutamide
- fluvoxamine
- furosemide
- ibandronate
- idelalisib
- ifosfamide
- iloperidone
- imipramine
- immune globulin intravenous
- immune globulin intravenous and subcutaneous
- inotersen
- interferon beta-1a
- interferon beta-1b
- iodamide
- iodipamide
- iodixanol
- iohexol
- iomeprol
- iopamidol
- iopromide
- iothalamate
- ioversol
- ioxaglate
- ioxilan
- maprotiline
- mavacamten
- meclizine
- melatonin
- melphalan
- mesalamine
- mesoridazine
- methadone
- methamphetamine
- methotrexate
- methotrimeprazine
- methoxyflurane
- metoclopramide
- metoprolol
- metrizamide
- mexiletine
- midodrine
- mipomersen
- mirtazapine
- monomethyl fumarate
- pamidronate
- paroxetine
- pegaspargase
- peginterferon beta-1a
- pemetrexed
- pentamidine
- pentoxifylline
- perphenazine
- pexidartinib
- pimozide
- pirfenidone
- pitolisant
- plazomicin
- polymyxin b
- promethazine
- propafenone
- propoxyphene
- propranolol
- protriptyline
- ramelteon
- ranolazine
- rasagiline
- remdesivir
- respiratory syncytial virus immune globulin
- rho (d) immune globulin
- riluzole
- risperidone
- ritonavir
- roflumilast
- roflumilast topical
- ropinirole
- ropivacaine
- tacrine
- tacrolimus
- tamoxifen
- tamsulosin
- tasimelteon
- telavancin
- telbivudine
- temsirolimus
- tenofovir alafenamide
- tenofovir disoproxil
- teriflunomide
- tetrabenazine
- theophylline
- thiabendazole
- thioguanine
- thioridazine
- timolol
- timolol ophthalmic
- tizanidine
- tobramycin
- tolterodine
- trabectedin
- tramadol
- trazodone
- trimethoprim
- trimipramine
Givosiran alcohol/food interactions
There is 1 alcohol/food interaction with givosiran.
Givosiran disease interactions
There is 1 disease interaction with givosiran which include:
More about givosiran
- givosiran consumer information
- Compare alternatives
- Side effects
- Dosage information
- During pregnancy
- Drug class: miscellaneous metabolic agents
- En español
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.